𝔖 Bobbio Scriptorium
✦   LIBER   ✦

4-year survival data of patients with advanced renal cell carcinoma treated with autologous tumor vaccine and subcutaneous administration of recombinant interleukin-2 and interferon-alpha2b

✍ Scribed by S. Pomer; J. Schuth; V. Schirrmacher; G. Staehler

Book ID
116167793
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
126 KB
Volume
31
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sequential treatment of patients with ad
Sequential treatment of patients with advanced renal cell carcinoma with autologous tumor vaccine and subcutaneous administration of recombinant interleukin-2 and interferon Ξ±2b
✍ S. Pomer; R. Thiele; V. Daniel; R. Weimer; H. LΓΆhrke; V. Schirrmacher; G. Staehl πŸ“‚ Article πŸ“… 1991 πŸ› Springer-Verlag 🌐 English βš– 820 KB

Thirty patients with advanced renal cell carcinoma (RCC), 23 of whom had distant metastases in at least one organ, were entered after nephrectomy into a protocol involving vaccination with Newcastle disease virus (NDV)-modified autologous tumour material, with a subsequent induction week and repetit

Thirteen-year, long-term efficacy of int
Thirteen-year, long-term efficacy of interferon 2Ξ± and interleukin 2-based home therapy in patients with advanced renal cell carcinoma
✍ Jens Atzpodien; Reinhard Hoffmann; Marcus Franzke; Christian Stief; Thomas Wande πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 98 KB

## Background: The goal of the current report was to demonstrate the long-term efficacy of outpatient subcutaneous (sc) interferon alpha (ifn-alpha) and sc interleukin 2 (il-2)-based combination regimens in patients with metastatic renal cell carcinoma. ## Methods: In three consecutive clinical t